Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

tDCS Over the Supplemental Motor Area for the Treatment of Tourette Syndrome

NCT03401996 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT03401996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03401996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
tDCS Over the Supplemental Motor Area for the Treatment of Tourette Syndrome
Lead sponsor
University of Calgary
Phase
Not applicable
Overall status
Unknown status
Start date
May 1, 2018
Completion date
April 30, 2021
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tourette syndrome